Center for Biomarker Research & Precision Medicine School of Pharmacy

Home

NIMH grant was awarded to integrate methylomic profiles with genotype and gene expression information from schizophrenia cases and controls

Dr. Karolina A. Aberg was awarded a Small Research Grant (R03) from the National Institute of Mental Health, entitled “Mediators of Methylomic Profiles in 1500 Schizophrenia Cases and Controls”. This study takes advantage of our methylome-wide association study data that we recently published and additional phenotype and extensive genotype information is available. For this project we propose a set of novel analysis that aims to find methylation markers and further improve our understanding of the role played by methylation in SZ pathogenesis. This goal will be achieved through data integration. For this purpose we will first conduct MWAS of environmental mediators and perform methylation quantitative trait locus (meQTL) analyses exploring potential regulatory differences between SZ cases and controls. In addition to the data that is generated by performing additional MWAS and meQTL analyses, we will also include other data sets such as GWAS and genome-wide mRNA expression that are directly related to SZ or of relevance for brain function.

VCU researchers receive $2.1 million grant to investigate genetic markers for schizophrenia

Read More

Deep Sequencing of Three Loci Implicated in Large-Scale Genome-Wide Association Study Smoking Meta-Analyses published in Nicotine & Tobacco Research

Read More

The Center received a $3 million NIH grant to study molecular marks left by adverse events in childhood

Read More

NIMH grant was awarded to integrate methylomic profiles with genotype and gene expression information from schizophrenia cases and controls

Read More

Methylome-Wide Association Study of Schizophrenia published in JAMA Psychiatry

Read More

Contribute

Amount Donate
Project
($5,000+)
Adopt